Discover trends, market shifts, and competitive outlooks for the intravenous immunoglobulin industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Intravenous Immunoglobulin Market Through 2034?

The market size for intravenous immunoglobulin has seen substantial growth in the recent past. The market is expected to expand from $14.66 billion in 2024 to $15.72 billion in 2025, marking a compound annual growth rate (CAGR) of 7.2%. This robust growth in the historic timeframe can be credited to factors such as the treatment of primary immunodeficiency disorders, management of neurological diseases, a surge in the elderly population, progress in plasma fractionation methods, broadened neurological indications, handling of infectious diseases, and the treatment of pediatric immunodeficiency.

The market for intravenous immunoglobulin is projected to experience substantial growth in the upcoming years, reaching $22.01 billion by 2029 with an annual compound growth rate (CAGR) of 8.8%. This expected growth can be linked to several factors such as a rising occurrence of autoimmune disorders, active immunology research, increasing healthcare spending, growing instances of cancer, innovative immunoglobulin products, and personalized medicine tactics. In the forecast period, we can anticipate trends such as treatments for primary immunodeficiency disorders (PIDD), swift progress in technology, strategic partnerships and collaborations, advancements in production methods, applications in neurology and hematology, and progress in immunotherapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp

Which Primay Drivers Are Accelerating Growth in the Intravenous Immunoglobulin Market?

The escalating number of older people will prompt expansion within the intravenous immunoglobulin market. Often referring to individuals who are over the age of 65, the geriatric population often face weakened immune responses and limited antibodies as a natural part of aging. This makes them more dependent on immunoglobulins to supply their bodies with essential antibodies, thereby boosting the demand for intravenous immunoglobulins and propelling the market. To illustrate, data from the Population Reference Bureau, a non-profit organization based in Kenya, anticipates an increase of 47% in the American population aged 65 and older, growing from 58 million in 2022 to 82 million by 2050. Furthermore, this age segment’s percentage within the total population is predicted to ascend from 17% to 23% in the same timeframe. Thus, the augmenting geriatric population indeed plays a significant role in advancing the intravenous immunoglobulin market.

Which Primary Segments of the Intravenous Immunoglobulin Market Are Driving Growth and Industry Transformations?

The intravenous immunoglobulin market covered in this report is segmented –

1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4) By End-User: Hospitals, Clinics, Home Care

Subsegments:

1) By Immunoglobulin G (IgG): Normal IgG, Specific IgG

2) By Immunoglobulin M (IgM): Normal IgM, Specific IgM

3) By Immunoglobulin A (IgA): Normal IgA, Specific IgA

4) By Immunoglobulin E (IgE): Normal IgE, Specific IgE

5) By Immunoglobulin D (IgD): Normal IgD, Specific IgD

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8538&type=smp

Which Regions Are Key Players in the Growth of the Intravenous Immunoglobulin Market?

North America was the largest region in the intravenous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Intravenous Immunoglobulin Industry Dynamics?

The intravenous immunoglobulin market is witnessing an escalating trend in product innovation. Market-leading corporations are particularly focused on introducing novel items such as liquid immune globulin formulations, used for immunodeficiency diseases treatment, to retain their market stature. For example, GC Pharma, a pharmaceutical company based in South Korea, launched Alyglo, a product approved by the US Food and Drug Administration (FDA), in December 2023. This ready-to-use sterile liquid formulation includes 10% immunoglobulin G (IgG), with each milliliter containing 100 mg of protein of which at least 96% originates from human IgG obtained from collected human plasma. It is specially aimed for the treatment of primary humoral immunodeficiency (PI) in adults 17 years or older. This covers diseases like congenital agammaglobulinemia, common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).

View the full report here:

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

What Parameters Are Used to Define the Intravenous Immunoglobulin Market?

Intravenous immunoglobulin refers to a therapy used for the treatment of immunodeficient people. It is administered in the form of intravenous infusion. Infusion liquid is made from immunoglobulins collected from healthy individuals and purified to eliminate any blood-borne infection or impurity.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8538

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model